Drugs@FDA document
XOPENEX HFA Pediatric Clinical Pharmacology Review · NDA 021730 SUPPL-36
Drugs@FDA document · LUPIN · Jan 1, 1900
Key facts
| Drug name | XOPENEX HFA |
|---|---|
| Document type | Pediatric Clinical Pharmacology Review |
| Application | NDA021730 |
| Submission | SUPPL-36 |
| Company | LUPIN |
| Document date | Jan 1, 1900 |
At a glance
- Efficacy-Pediatric Document categories
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: